title: IL-16 anti-HIV-1 therapy.
authors.forename: G A
authors.initials: GA
authors.lastname: Viglianti
authors.forename: N A
authors.initials: NA
authors.lastname: Parada
authors.forename: J W
authors.initials: JW
authors.lastname: Maciaszek
authors.forename: H
authors.initials: H
authors.lastname: Kornfeld
authors.forename: D M
authors.initials: DM
authors.lastname: Center
authors.forename: W W
authors.initials: WW
authors.lastname: Cruikshank
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000821:virology; D005814:Genes, Viral / Q000187:drug effects; D005818:Genetic Engineering; D015658:HIV Infections / Q000276:immunology / Q000628:therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity*; D006801:Humans; D066298:In Vitro Techniques; D019410:Interleukin-16 / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D019410:Interleukin-16